When President Biden took office, the country was in the grip of a global pandemic. Businesses were shuttering, schools were closing, and people were dying. The country needed leadership.
The company behind a COVID-19 vaccine touted as a key tool for the developing world will miss a target for giving doses to the U.N.-backed effort to deliver shots to poorer countries.
Global achievements in reducing malaria cases and deaths in the past decades may be in danger of significant reversal if the problem of counterfeiting continues.